Rapid fluorescent assay for screening drugs on Leishmania amastigotes.
about
An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophagesIdentification of the molecular attributes required for aminoglycoside activity against LeishmaniaComparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screeningLuciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitroDevelopment and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity.Allopurinol Resistance in Leishmania infantum from Dogs with Disease RelapseAsteraceae Artemisia campestris and Artemisia herba-alba Essential Oils Trigger Apoptosis and Cell Cycle Arrest in Leishmania infantum PromastigotesMetabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical diseaseAnti-leishmanial activity of betulin derivatives.Early stage efficacy and toxicology screening for antibiotics and enzyme inhibitors.Identification of a secreted casein kinase 1 in Leishmania donovani: effect of protein over expression on parasite growth and virulence.From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity.Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis.Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection.Visceral leishmaniasis: experimental models for drug discovery.Synthesis and antileishmanial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivativesStudies on the antileishmanial properties of the antimicrobial peptides temporin A, B and 1Sa.Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay.Use of in vivo and in vitro systems to select Leishmania amazonensis expressing green fluorescent protein.In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.Genome wide comparison of Ethiopian Leishmania donovani strains reveals differences potentially related to parasite survival.Development of an automated image analysis protocol for quantification of intracellular forms of Leishmania sppAntiprotozoal activity of dehydroabietic acid derivatives against Leishmania donovani and Trypanosoma cruziSynthesis of carboxyimidamide-substituted benzo[c][1,2,5]oxadiazoles and their analogs, and evaluation of biological activity against Leishmania donovaniHeterocycle-fused lupane triterpenoids inhibit Leishmania donovani amastigotes
P2860
Q27305418-D553F5D3-7D6F-4BB9-86AC-6F7D1B352001Q27679272-46C0489E-1FEC-4CC3-B68E-04BF47FFFA11Q28475069-BE7ACA83-01EC-4622-A236-773B08750088Q28477052-F30D768C-D168-4764-AD53-8E79D345B1DAQ28548536-68DE6174-8C01-46F5-959A-1D8ED32E173AQ28552396-51C23E71-3D10-42D4-968C-5D82C9828E30Q28821108-9A8C4A79-0AAD-4AB9-ADD4-A9CCE8576E0BQ30426102-42B5672C-3006-4B20-B9F7-FA5BD085E747Q33530052-A0436B72-DAA7-4700-91FF-A7BE853CAEABQ34213192-86928E01-F3B1-4C43-971C-B8E6EEBC1084Q35048303-B4A5D9E2-377A-4A0B-9AC2-8788CB40ACFDQ35931675-3E373FBD-78A7-4937-A6A6-FE46260B6595Q37390578-F9A7D7E5-A7A0-4163-8DE1-76CF61EB9D53Q37643636-C52712DA-C99F-4E93-ACEC-067B45D66CEEQ37842069-E4C36768-3B58-479E-8AE1-0E7F41696784Q38909747-99BE9789-800F-49A4-956E-7A6DE0035B36Q38936646-9E19A877-CBB4-437F-912C-5E8C48DFDC57Q38966911-EC4CDF14-88EF-4709-9B17-EB6A98007B7AQ41125410-03CC97D3-ECFA-4EDF-A1D5-908277AAD4D3Q41844113-76325B76-C213-4AC8-9A3B-A4D01D7B054FQ48284181-FE3F5758-B5FC-4D21-8711-17036F505FFFQ58803746-0FF90C41-FCCD-4CF8-9556-856626A90303Q58848333-9FD17D3C-C4CA-422F-916E-E9A5E7167C2AQ58898624-BBB3632B-6C0A-419C-8827-ABF5BC8DDC2BQ58898626-2079E7BB-7101-45A8-9FF3-68C94ED021FF
P2860
Rapid fluorescent assay for screening drugs on Leishmania amastigotes.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Rapid fluorescent assay for screening drugs on Leishmania amastigotes.
@ast
Rapid fluorescent assay for screening drugs on Leishmania amastigotes.
@en
type
label
Rapid fluorescent assay for screening drugs on Leishmania amastigotes.
@ast
Rapid fluorescent assay for screening drugs on Leishmania amastigotes.
@en
prefLabel
Rapid fluorescent assay for screening drugs on Leishmania amastigotes.
@ast
Rapid fluorescent assay for screening drugs on Leishmania amastigotes.
@en
P1476
Rapid fluorescent assay for screening drugs on Leishmania amastigotes.
@en
P2093
Charles L Jaffe
Orly Shimony
P304
P356
10.1016/J.MIMET.2008.05.026
P577
2008-06-05T00:00:00Z